Journal of Cancer Research and Treatment
ISSN (Print): 2374-1996 ISSN (Online): 2374-2003 Website: http://www.sciepub.com/journal/jcrt Editor-in-chief: Jean Rommelaere
Open Access
Journal Browser
Go
Journal of Cancer Research and Treatment. 2019, 7(1), 21-26
DOI: 10.12691/jcrt-7-1-4
Open AccessReview Article

The Nanoformulations of Curcumin for Cancer Therapy: New Perspectives

Aisha H. Al-Shehri1, Ahmed M. Kabel2, 3, and Maaly A. Abd Elmaaboud2

1King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia

2Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt

3Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia

Pub. Date: August 23, 2019

Cite this paper:
Aisha H. Al-Shehri, Ahmed M. Kabel and Maaly A. Abd Elmaaboud. The Nanoformulations of Curcumin for Cancer Therapy: New Perspectives. Journal of Cancer Research and Treatment. 2019; 7(1):21-26. doi: 10.12691/jcrt-7-1-4

Abstract

Curcumin is a natural yellow phenolic compound that is located in many types of herbs, especially Curcuma Lana (Turmeric). It is a natural anti-oxidant and has shown many pharmaceutical activities in the preclinical and clinical studies such as antioxidant, anti-microbial, anti-cancer and anti-alzheimer disease effects. In addition, curcumin was proven to be anti-diabetic, hepatoprotective, neuroprotective and anti-rheumatic and it also protects against thrombosis and myocardial infarction. The major limitation to the use of curcumin in clinical practice is its very low oral bioavailability. Therefore, many technologies have been developed and implemented to overcome this limitation. In this review, we discussed the latest perspectives regarding the design and development of nano-sized systems for the anti-diabetic agent curcumin, including liposomes, polymeric nanoparticles, micro-conjugates, micelles, peptide carriers, solid dispersions, cyclodextrins, emulsions and lipid nanopeptides and their role as a promising hope for cancer therapy.

Keywords:
curcumin nanoformulations cancer perspectives

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. Journal of Thoracic Disease 2017; 9(3): 448-51.
 
[2]  Kabel AM, Abd Elmaaboud MA. Cancer: Role of Nutrition, Pathogenesis, Diagnosis and Management. World Journal of Nutrition and Health 2014; 2(4): 48-51.
 
[3]  Macedo F, Ladeira K, Pinho F, et al. Bone Metastases: An Overview. Oncology Reviews 2017; 11(1): 321.
 
[4]  Kabel AM, Al-Shehri AH, Al-Talhi RA, Abd Elmaaboud MA. The promising effect of linagliptin and/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome. Chemico-Biological Interactions 2017; 273: 190-9.
 
[5]  Hewlings SJ, Kalman DS. Curcumin: A Review of Its’ Effects on Human Health. Foods 2017;6(10):92.
 
[6]  Hallman K, Aleck K, Dwyer B, et al. The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells. Breast Cancer : Targets and Therapy 2017; 9: 153-61.
 
[7]  Prasad S, Tyagi AK, Aggarwal BB. Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice. Cancer ResTreat 2014; 46(1): 2-18.
 
[8]  Gera M, Sharma N, Ghosh M, et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget 2017; 8(39): 66680-98.
 
[9]  Yallapu MM, Nagesh PKB, Jaggi M, Chauhan SC. Therapeutic Applications of Curcumin Nanoformulations. The AAPS Journal 2015; 17(6): 1341-56.
 
[10]  Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials 2014; 35(10):3365-83.
 
[11]  Rachmawati H, Yanda YL, Rahma A, Mase N. Curcumin-Loaded PLA Nanoparticles: Formulation and Physical Evaluation. Scientia Pharmaceutica 2016;84(1):191-202.
 
[12]  Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology 2007; 5: 3.
 
[13]  Ford Versypt AN, Pack DW, Braatz RD. Mathematical modeling of drug deliveryfrom autocatalytically degradable PLGA microspheresda review.J Control Release 2013; 165: 29-37.
 
[14]  Shaikh J, Ankola D, Beniwal V, Singh D, Kumar M. Nanoparticle encapsulationimproves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J PharmSci 2009; 37: 223e30.
 
[15]  Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. Fabrication of curcuminencapsulated PLGA nanoparticles for improved therapeutic effects in metastaticcancer cells. J Colloid Interface Sci 2010; 351: 19-29.
 
[16]  Ghosh D, Choudhury ST, Ghosh S, Mandal AK, Sarkar S, Ghosh A, et al. Nanocapsulated curcumin: oral chemopreventive formulation againstdiethylnitrosamine induced hepatocellular carcinoma in rat. Chem BiolInteract 2012; 195: 206-14.
 
[17]  Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhancedcellularuptake, and increased bioactivity in vitro and superior bioavailabilityin vivo. Biochem Pharmacol 2010; 79: 330-8.
 
[18]  Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Experimental and molecular pathology 2009; 86(3): 215-23.
 
[19]  Rejinold N, Sreerekha P, Chennazhi K, Nair S, Jayakumar R. Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide)nanocarrier for curcumin drug delivery. Int J Biol Macromol. 2011; 49: 161-72.
 
[20]  Pandit RS, Gaikwad SC, Agarkar GA, Gade AK, Rai M. Curcumin nanoparticles: physico-chemical fabrication and its in vitro efficacy against human pathogens. 3 Biotech 2015; 5(6): 991-7.
 
[21]  Udompornmongkol P, Chiang BH. Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications. J BiomaterAppl 2015; 30(5): 537-46.
 
[22]  Liu M, Du H, Zhai G. The Design of Amphiphilic Polymeric Micelles of Curcumin for Cancer Management. Curr Med Chem 2015; 22(38): 4398-411.
 
[23]  Zhang Y, Huang Y, Li S. Polymeric Micelles: Nanocarriers for Cancer-Targeted Drug Delivery. AAPS PharmSciTech 2014; 15(4): 862-71.
 
[24]  Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J.Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A 2008; 86(2): 300-10.
 
[25]  Gong C, Deng S, Wu Q, Xiang M, Wei X, Li L, Gao X, Wang B, Sun L, Chen Y, Li Y, Liu L, Qian Z, Wei Y. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 2013; 34(4): 1413-32.
 
[26]  Mahmud M, Piwoni A, Filiczak N, Janicka M, Gubernator J. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro. Ahmad A, ed. PLoS ONE 2016; 11(12): e0167787.
 
[27]  Feng T, Wei Y, Lee RJ, Zhao L. Liposomal curcumin and its application in cancer. International Journal of Nanomedicine 2017; 12: 6027-44.
 
[28]  Vieira DB, Gamarra LF. Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. International Journal of Nanomedicine 2016; 11: 5381-414.
 
[29]  Chen C-H, Lin Y-L, Liu Y-K, et al. Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch. International Journal of Nanomedicine 2012; 7: 607-21.
 
[30]  Rahimi HR, Nedaeinia R, SepehriShamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna Journal of Phytomedicine 2016; 6(4): 383-98.
 
[31]  Manju S, Sreenivasan K. Conjugation of curcuminonto hyaluronic acid enhances its aqueous solubility and stability. J Colloid Interface Sci 2011; 359: 318-25.
 
[32]  Chen Y-N, Hsu S-L, Liao M-Y, et al. Ameliorative Effect of Curcumin-Encapsulated Hyaluronic Acid–PLA Nanoparticles on Thioacetamide-Induced Murine Hepatic Fibrosis. Chang H-T, ed. International Journal of Environmental Research and Public Health 2017; 14(1): 11.
 
[33]  Wichitnithad W, Nimmannit U, Callery PS, Rojsitthisak P. Effects of different carboxylic ester spacers on chemical stability, release characteristics, andanticancer activity of mono-PEGylated curcumin conjugates. J Pharm Sci 2011; 100: 5206-18.
 
[34]  Davatgaran-Taghipour Y, Masoomzadeh S, Farzaei MH, et al. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinicalperspective. International Journal of Nanomedicine 2017; 12: 2689-702.
 
[35]  Song Z, Lu Y, Zhang X, Wang H, Han J, Dong C. Novel curcumin-loaded human serum albumin nanoparticles surface functionalized with folate: characterization and in vitro/vivo evaluation. Drug Design, Development and Therapy 2016; 10: 2643-9.
 
[36]  Singh A, Bajpai J, Bajpai AK. Investigation of magnetically controlled water intake behavior of Iron Oxide Impregnated Superparamagnetic Casein Nanoparticles (IOICNPs). Journal of Nanobiotechnology 2014; 12: 38.
 
[37]  Mock CD, Jordan BC, Selvam C. Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment. RSC advances 2015; 5(92): 75575-88.
 
[38]  Hagbani TA, Nazzal S. Curcumin complexation with cyclodextrins by the autoclave process: Method development and characterization of complex formation. Int J Pharm 2017; 520(1-2): 173-180.
 
[39]  Yeh C-C, Su Y-H, Lin Y-J, et al. Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis. Drug Design, Development and Therapy 2015; 9: 2285-300.
 
[40]  Mirzaei H, Shakeri A, Rashidi B, Jalili A1, Banikazemi Z, Sahebkar A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother 2017; 85: 102-12.
 
[41]  Rocks N, Bekaert S, Coia I, et al. Curcumin–cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. British Journal of Cancer 2012; 107(7): 108392.
 
[42]  Chaturvedi M, Kumar M, Pathak K, Bhatt S, Saini V. Surface Solid Dispersion and Solid Dispersion of Meloxicam: Comparison and Product Development. Advanced Pharmaceutical Bulletin 2017; 7(4): 569-77.
 
[43]  Gidwani B, Vyas A. A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs. BioMed Research International 2015; 2015: 198268.
 
[44]  Teixeira CCC, Mendonça LM, Bergamaschi MM, et al. Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity. AAPS PharmSci Tech 2016; 17(2): 252-61.
 
[45]  Chen L-C, Chen Y-C, Su C-Y, Wong W-P, Sheu M-T, Ho H-O. Development and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin. Sci Rep 2016; 6: 37122.
 
[46]  Anuchapreeda S, Fukumori Y, Okonogi S, Ichikawa H. Preparation of lipid nanoemulsions incorporating curcumin for cancer therapy. J Nanotechnol 2012; 41: 1-11.
 
[47]  Zanotto-Filho A, Coradini K, Braganhol E, Schröder R, de Oliveira CM, Simões- Pires A, et al. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur J Pharm Biopharm 2013; 83: 156-67.
 
[48]  Anselmo AC, Mitragotri S. Nanoparticles in the clinic. Bioengineering & Translational Medicine 2016; 1(1): 10-29.
 
[49]  Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 2010; 58: 2095-9.
 
[50]  Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K. Doseescalationand pharmacokinetic study of nanoparticle curcumin, a potentialanticancer agent with improved bioavailability, in healthy human volunteers.Cancer Chemother Pharm 2012; 69: 65-70.
 
[51]  Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T. Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 2011; 34: 660-5.
 
[52]  Park W, Amin AR. R, Chen ZG, Shin DM. New perspectives of curcumin in cancer prevention. Cancer prevention research (Phila) 2013; 6(5): 387-400.
 
[53]  Kanai M. Therapeutic applications of curcumin for patients with pancreatic cancer. World JGastroenterol 2014; 20(28): 9384-91.
 
[54]  Kang M, Ho JN, Kook HR, Lee S, Oh JJ, Hong SK, Lee SE, Byun SS. Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest. Oncol Rep 2016; 35(3): 1463-72.
 
[55]  Kooijmans SA, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM. Exosomemimetics: a novel class of drug delivery systems. Int J Nanomed 2012; 7: 1525-41.
 
[56]  Wang J, Zheng Y, Zhao M. Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells. Frontiers in Pharmacology 2016; 7: 533.
 
[57]  Gavrilas LI, Ionescu C, Tudoran O, Lisencu C, Balacescu O, Miere D. The Role of Bioactive Dietary Components in Modulating miRNA Expression in Colorectal Cancer. Nutrients 2016; 8(10): 590.
 
[58]  Fadus MC, Lau C, Bikhchandani J, Lynch HT. Curcumin: An age-old anti-inflammatory and anti-neoplastic agent. Journal of Traditional and Complementary Medicine. 2017; 7(3): 339-46.
 
[59]  Magnuson B, Munro I, Abbot P, et al. Review of the regulation and safety assessment of food substances in various countries and jurisdictions. Food Additives & Contaminants Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment 2013; 30(7): 1147-220.
 
[60]  Yallapu MM, Jaggi M, Chauhan SC. Curcumin Nanomedicine: A Road to Cancer Therapeutics. Current pharmaceutical design 2013; 19(11): 1994-2010.